Chimeric antibody immune effector cell engagers and methods of use thereof
US11827713B2 · kind B2 · utility
0Cited by
18References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 2018 |
| Grant date | Nov 28, 2023 |
| Priority date | — |
| Expiry date | Nov 19, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a chimeric antibody immune cell engager comprising a target cell binding domain that specifically binds to an antigen on a target cell, and an immune effector cell binding domain comprising an antigen-binding fragment that specifically binds to an antigen on an immune effector cell. Also provided are pharmaceutical compositions, kits and methods of treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.